Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer The Randomized Clinical FinXX Trial

Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Riitta Kokko, Johan Ahlgren, Paivi Auvinen, Outi Lahdenpera, Sanna Kosonen, Kenneth Villman, Paul Nyandoto, Greger Nilsson, Paula Poikonen-Saksela, Vesa Kataja, Jouni Junnila, Petri Bono, Henrik Lindman

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJAMA Oncology
Volume3
Issue number6
Pages (from-to)793-800
Number of pages8
ISSN2374-2437
DOIs
Publication statusPublished - Jun 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • DOSE-DENSE CHEMOTHERAPY
  • PHASE-III
  • PLUS DOCETAXEL
  • NEOADJUVANT TREATMENT
  • THERAPY
  • 5-FLUOROURACIL
  • METAANALYSIS
  • TRASTUZUMAB
  • BEVACIZUMAB
  • PACLITAXEL
  • 3122 Cancers

Cite this